GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » Ending Cash Position

ABTI (Alterola Biotech) Ending Cash Position : $0.01 Mil (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Alterola Biotech Ending Cash Position?

Alterola Biotech's Ending Cash Position for the quarter that ended in Jun. 2024 was $0.01 Mil.

Alterola Biotech's quarterly Ending Cash Position stayed the same from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($0.00 Mil) but then increased from Mar. 2024 ($0.00 Mil) to Jun. 2024 ($0.01 Mil).

Alterola Biotech's annual Ending Cash Position declined from Mar. 2022 ($0.06 Mil) to Mar. 2023 ($0.01 Mil) and declined from Mar. 2023 ($0.01 Mil) to Mar. 2024 ($0.00 Mil).


Alterola Biotech Ending Cash Position Historical Data

The historical data trend for Alterola Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech Ending Cash Position Chart

Alterola Biotech Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Mar22 Mar23 Mar24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.06 0.01 -

Alterola Biotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.01 - - 0.01

Alterola Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alterola Biotech's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.009+-0.006
=0.00

Alterola Biotech's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.002+0.009
=0.01


Alterola Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Alterola Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Alterola Biotech Business Description

Traded in Other Exchanges
N/A
Address
47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR
Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.
Executives
Bright Green Corp 10 percent owner 401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301